Immune protein a possible target to slow Parkinson's disease
May 12, 2026
May 12, 2026
PHILADELPHIA, Pennsylvania, May 12 -- The University of Pennsylvania Perelman School of Medicine posted the following news:
* * *
Immune protein a possible target to slow Parkinson's disease
*
Monoclonal antibodies can block a key immune-related protein that drives the spread of brain cell damage in Parkinson's disease (PD). This protein, called glycoprotein nonmetastatic melanoma B (GPNMB), might be part of a promising strategy for d . . .
* * *
Immune protein a possible target to slow Parkinson's disease
*
Monoclonal antibodies can block a key immune-related protein that drives the spread of brain cell damage in Parkinson's disease (PD). This protein, called glycoprotein nonmetastatic melanoma B (GPNMB), might be part of a promising strategy for d . . .